Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
CONCLUSION: Dietary modulation of inflammatory and neuroendocrine pathways represents a promising complementary approach to PCOS therapy. Further clinical research is needed to validate efficacy, optimize formulations, and ensure the safety of such integrative treatments.
Published on: Sun, 01 Mar 2026 06:00:00 -0500
Authors: Divyanshi Gupta, Lucy Mohapatra, Ankita Wal,
No abstract
Published on: Sun, 01 Mar 2026 06:00:00 -0500
Authors: Shaoqian Zhao, Yuyao Zou, Zhifeng Wang, Lingxia Ye, Yufei Chen, Zhiwen Cao, Xiaoqiang Xu, Aibo Gao, Xiayang Ying, Mengmin Chen, Kai Qin, Yifei Zhang, Weiqiong Gu, Jiqiu Wang, Guang Ning, Weiqing Wang, Ruixin Liu, Jiabin Jin, Jie Hong,
Selenium plays a crucial role in maintaining metabolic health, providing antioxidant protection, and modulating inflammation. Further clarification of the physiological functions and pathological relevance of selenium is necessary to increase understanding of its therapeutic potential through supplementation and to determine the most effective strategies across different populations and metabolic conditions. We sought to systematically map and synthesize existing evidence on the effects of...
Published on: Sat, 28 Feb 2026 06:00:00 -0500
Authors: Linda Morales-Juárez, Astrid Domínguez-Uscanga, Janet A Gutiérrez-Uribe, Diego A Luna-Vital, Anayansi Escalante-Aburto,
CONCLUSION: Anxiety, depression, blood sugar status and LDL-c are key factors influencing sleep disorders in patients with PCOS after ketogenic diet intervention. A prediction model featuring high accuracy and remarkable clinical utility was successfully established.
Published on: Sat, 28 Feb 2026 06:00:00 -0500
Authors: Mengxiao Xie, Jian Li, Wengpei Bai,
CONCLUSION: GH is causatively linked to higher stroke risk in women, underscoring the need for focused monitoring and interventions to mitigate long-term health risks in this group.
Published on: Sat, 28 Feb 2026 06:00:00 -0500
Authors: Haizhao Luo, Wen Mei, Jingwen Ye, Lei Liu, Weiqiang Liang, Yi Shu,
Although Myo-Inositol/D-Chiro-Inositol (Ins) and berberine (BBR) have each shown beneficial effects in polycystic ovary syndrome (PCOS), their combined therapeutic potential has not been systematically evaluated. Here, we demonstrate that Ins/BBR exerts superior efficacy compared with single treatments by targeting multiple pathogenic pathways in PCOS. In a DHEA+HFD-induced mouse model, Ins/BBR restored systemic sex steroid balance, normalized LH/FSH ratio, and improved estrous cyclicity. It...
Published on: Sat, 28 Feb 2026 06:00:00 -0500
Authors: Juan Ge, Chenxiang Zhang, Yilong Zhao, Haiyang Zhao, Shuai Zhu, Tao Tang, Guorui Zhang, Qiang Wang, Hui Wang,
No abstract
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Jun Liu, Li Wang, Min Jiang, Heqiu Yan, Guohui Zhang, Ningjing Li, Yuhong Zhao, Xinrong Du, Qin Zeng, Dongsheng Xiong, Libing He, Zhuoting Zhou, Mengjun Luo, Weixin Liu,
No abstract
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Kim van der Ham, Johanna Sillman, Martin Hund, Anika Mang, Yvonne V Louwers, Joop S E Laven,
CONCLUSIONS: PCOS patients with acne had inadequate knowledge, active attitude and proactive practice towards disease and self-management. To enhance clinical practice, targeted educational interventions are recommended, specifically addressing the knowledge gaps observed in unemployed individuals and those in the early stages of PCOS.
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Xiaoli Kou, Shimeng Ma, Xingmo Li, Danning Pei, Guoqiang Zhang, Zhiqiang Zhang,
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder associated with psychological challenges. Non-pharmaceutical interventions may improve psychological well-being in affected women. This systematic review and meta-analysis compares mental health changes between PCOS women receiving non-pharmaceutical interventions and controls. Ten English and Chinese databases were searched up to May 25, 2025. Eligible studies included women aged ≥16 years with clinically diagnosed PCOS, employed...
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Margaret Xi Can Yin, Meng-Yi Huang, Yi-Fei Zhao, Xuan-Yu Chen,
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age and cannot currently be cured or prevented fundamentally. Prenatal androgen exposure is a key factor in PCOS development, and both PCOS patients and animal models exhibit gut microbiota alterations. We previously demonstrated that prenatally androgenized (PNA) model mice display changes of gut microbiota before the manifestation of PCOS phenotypes, suggesting that an intervention targeting...
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Nanoka Sakaguchi, Akari Kusamoto, Miyuki Harada, Babita Shashni, Airi Komura, Ayaka Teshima, Tsurugi Tanaka, Hiroshi Koike, Zixin Xu, Yuma Kawahara, Chihiro Tsuchida, Chisato Kunitomi, Nozomi Takahashi, Yoko Urata, Osamu Wada-Hiraike, Yasushi Hirota, Yukio Nagasaki, Yutaka Osuga,
CONCLUSIONS: In this model of pre-established obesity and hyperandrogenism, butyrate supplementation was not metabolically protective. Instead, it was associated with worsened adipose inflammation, altered adipokine profiles, and impaired glucose regulation. These findings highlight the context-dependent nature of butyrate's effects and caution against its generalization as a universally beneficial metabolic modulator.
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Mariana Muros Ferreira, Yasmin Silva Frank, Giuliana Petri, Juliana Mora Veridiano, Nuha Ahmad Dsouki, Beatriz da Costa Aguiar Alves Reis, Carina Ulsen, Jhonatan Jair Arismendi Florez, Luciano Melo Pompei, Marcelo Luiz Steiner, Bianca Bianco,
CONCLUSIONS: Consuming 460 mg of Arctium lappa L. root powder daily for 12 weeks can reduce ovarian volume and lower oxidative stress and inflammation in women with polycystic ovary syndrome.
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Hanieh Taheri, Fatemeh Seydi, Farideh Jalali-Mashayekhi, Azam Moslemi, Heidar Farahani, Ali Khosrowbeygi,
In vitro maturation (IVM) of human oocytes, once a pioneering concept predating conventional IVF, has long remained an underutilized technique in assisted reproduction. Despite early promise, clinical adoption of IVM has been limited due to lower embryo developmental competence and live birth rates compared to IVF. However, recent advances in the understanding of oocyte physiology, including cumulus-oocyte communication, the regulatory roles of cAMP/cGMP signaling pathways, and endocrine...
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Marcos Iuri Roos Kulmann, Gabriella Mamede Andrade, Adriana Bos-Mikich, Norma Pagnoncelli de Oliveira, Marcelo Ferreira, Nilo Frantz,
CONCLUSION: Inositol improves core PCOS manifestations. Supported by moderate-quality evidence for effects on TT, FT, SHBG, HOMA-IR, and pregnancy/ovulation rates, it is a promising therapy. Differential efficacy of inositol subtypes may inform personalized treatment. However, outcomes based on low-quality evidence require cautious interpretation and should not solely guide clinical decisions, highlighting the need for larger, rigorous trials.
Published on: Fri, 27 Feb 2026 06:00:00 -0500
Authors: Mengxue Duan, Min Yang, Chang Li, Xiao Wu, Xiaoxiao Yin, Hongqiu Zhu,